Summary. Viable human pancreatic islets isolated from a recent-onset Type 1 (insulin-dependent) diabetic patient were used to perform in vitro studies. Pre-proinsulin mRNA and insulin content, as well as insulin response were analyse d . Insulin response to glucose and forskolin was completely absent in diabetic islets, as compared to control islets. Insulin content was reduced to only one-third of control values (395.0 + 3.5 vs 989.0 _+ 46.3 gU/islet) and 20.7 + 3.9 % of islets from the diabetic pancreas contained insulin-positive cells in immunofluorescence studies. Northern blot analysis revealed a severe reduction in the content of pre-proinsulin mRNA in diabetic pancreatic tissue. Our results indicate that although markedly decreased, beta cells in human pancreatic islets at the onset of Type 1 diabetes are still present. Nevertheless, pancreatic islet function is disproportionately impaired with a complete absence of an insulin response.
Key words:Human islets, islet function, onset of Type 1 (insulin-dependent) diabetes mellitus.Type i (insulin-dependent) diabetes mellitus is an autoimmune disease caused by the selective destruction of islet beta cells. Attempts have been made to define the immunopathological aspects of this destruction. This has shown that pancreatic tissue from newly-diagnosed Type i diabetic patients presents several distinct features including: severely reduced beta-cell mass, various degrees of expression of MHC class I and class II antigens in islet cells and lymphocytic infiltrates [1][2][3]. However, the beta-cell secretory function of this clinical entity has only been evaluated in in vivo studies [4].We report here the first study in which viable human pancreatic islets were isolated from a recent-onset Type 1 diabetic patient and thus were used to perform in vitro functional studies.
Subjects and methodsAfter obtaining the family's informed consent and with the approval of the Hospital Ethics Committee, human pancreatic islets were isolated from the pancreas of a islet cell antibody positive 18-year-old woman who had died 6 h after her admission because of diabetic ketoacidosis. She had been asymptomatic up to 2 days prior to admission when polydipsia, polyuria and polyphagia were observed. Islets were obtained following a modification of Ricordi's automatic digestion technique [5]. The pancreas from the diabetic patient was treated in the same manner as the pancreata obtained from the control cadaveric organ donors with a similar time period between death and pancreas removal. Briefly, after the pancreatic duct was cannulated, Hanks' balanced salt solution (HBSS) at 37 ~ containing 1% newborn calf serum (NCS; Gibco, Paisley, UK), 2.5 mg/ml collagenase (Type P; Boehringer Mannheim, Mannheim, FRG) and 0.04mg/ml deoxyribonuclease (DNAseI; Sigma, St.Louis, Mo., USA) was injected. The pancreas was loaded into a digestion chamber and was connected to a closed circuit with recircularization of the medium and continuously shaken. Samples were taken every 3 min, stained with dithizone ...